BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 22644022)

  • 1. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.
    Cai D; Mills C; Yu W; Yan R; Aldrich CE; Saputelli JR; Mason WS; Xu X; Guo JT; Block TM; Cuconati A; Guo H
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4277-88. PubMed ID: 22644022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
    Sheraz M; Cheng J; Tang L; Chang J; Guo JT
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
    Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic Analysis of Nuclear Hepatitis B Virus Relaxed Circular DNA-Associated Proteins Identifies UV-Damaged DNA Binding Protein as a Host Factor Involved in Covalently Closed Circular DNA Formation.
    Marchetti AL; Zhang H; Kim ES; Yu X; Jang S; Wang M; Guo H
    J Virol; 2022 Jan; 96(2):e0136021. PubMed ID: 34705558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.
    Zhao Q; Chang J; Rijnbrand R; Lam AM; Sofia MJ; Cuconati A; Guo JT
    J Virol; 2022 Dec; 96(24):e0115022. PubMed ID: 36448800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct dual antiviral mechanism that enhances hepatitis B virus mutagenesis and reduces viral DNA synthesis.
    McDaniel YZ; Patterson SE; Mansky LM
    Antiviral Res; 2019 Oct; 170():104540. PubMed ID: 31247245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.
    Qi Y; Gao Z; Xu G; Peng B; Liu C; Yan H; Yao Q; Sun G; Liu Y; Tang D; Song Z; He W; Sun Y; Guo JT; Li W
    PLoS Pathog; 2016 Oct; 12(10):e1005893. PubMed ID: 27783675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of Host ATR-CHK1 Pathway in Hepatitis B Virus Covalently Closed Circular DNA Formation.
    Luo J; Luckenbaugh L; Hu H; Yan Z; Gao L; Hu J
    mBio; 2020 Feb; 11(1):. PubMed ID: 32071277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA.
    Tang L; Sheraz M; McGrane M; Chang J; Guo JT
    PLoS Pathog; 2019 Apr; 15(4):e1007742. PubMed ID: 31026293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the Termini of Cytoplasmic Hepatitis B Virus Deproteinated Relaxed Circular DNA.
    Cai D; Yan R; Xu JZ; Zhang H; Shen S; Mitra B; Marchetti A; Kim ES; Guo H
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33055252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of Hepatitis B Virus Nuclear DNA.
    Li M; Sohn JA; Seeger C
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx.
    Cheng ST; Hu JL; Ren JH; Yu HB; Zhong S; Wai Wong VK; Kwan Law BY; Chen WX; Xu HM; Zhang ZZ; Cai XF; Hu Y; Zhang WL; Long QX; Ren F; Zhou HZ; Huang AL; Chen J
    J Hepatol; 2021 Mar; 74(3):522-534. PubMed ID: 32987030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
    Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
    J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation.
    Guo H; Jiang D; Zhou T; Cuconati A; Block TM; Guo JT
    J Virol; 2007 Nov; 81(22):12472-84. PubMed ID: 17804499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus.
    Kitamura K; Que L; Shimadu M; Koura M; Ishihara Y; Wakae K; Nakamura T; Watashi K; Wakita T; Muramatsu M
    PLoS Pathog; 2018 Jun; 14(6):e1007124. PubMed ID: 29928064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation.
    Wei ZQ; Zhang YH; Ke CZ; Chen HX; Ren P; He YL; Hu P; Ma DQ; Luo J; Meng ZJ
    World J Gastroenterol; 2017 Sep; 23(34):6252-6260. PubMed ID: 28974891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide impacts hepatitis B virus core nuclear localization and efficiently interferes with HBV infection.
    Hofmann S; Luther J; Plank V; Oswald A; Mai J; Simons I; Miller J; Falcone V; Hansen-Palmus L; Hengel H; Nassal M; Protzer U; Schreiner S
    Microbiol Spectr; 2024 May; 12(5):e0378823. PubMed ID: 38567974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and mechanistic study of Imperatorin that inhibits HBsAg expression and cccDNA transcription.
    Ren F; Zhao S; He X; Lo H; Wong VKW; Law BYK; Wu A; Zhang J
    J Med Virol; 2024 May; 96(5):e29669. PubMed ID: 38773784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hydrolyzable tannins (punicalagin, punicalin and geraniin) as novel inhibitors of hepatitis B virus covalently closed circular DNA.
    Liu C; Cai D; Zhang L; Tang W; Yan R; Guo H; Chen X
    Antiviral Res; 2016 Oct; 134():97-107. PubMed ID: 27591143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line.
    Ogura N; Watashi K; Noguchi T; Wakita T
    Biochem Biophys Res Commun; 2014 Sep; 452(3):315-21. PubMed ID: 25150444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.